Search for a doctor

W Ray Kim, M.D.

Request an Appointment

Publications

  1. Chen VL, Morgan TR, Rotman Y, Patton HM, Cusi K, Kanwal F, Kim WR. Reply: AASLD Resmetirom Guidance. Hepatology. 2025 Jun 1; 81 (6):E164-E165 Epub 2025 Feb 14
    View PubMed
  2. Kim WR, Sripongpun P, Mannalithara A, Charu V. Letter to the editor: How to count from 0 to 4 without skipping a number. Hepatology. 2025 May 8 Epub 2025 May 08
    View PubMed
  3. Charu V, Kim WR, Kwong AJ. PRO MELD: MELD is the best method of prioritization for liver transplantation. Liver Transpl. 2025 Apr 22 [Epub ahead of print]
    View PubMed
  4. Norman JS, Mehta N, Kim WR, Liang JW, Biggins SW, Asrani SK, Heimbach J, Charu V, Kwong AJ. Model of Urgency for Liver Transplantation in Hepatocellular Carcinoma: A Practical Model to Prioritize Patients With Hepatocellular Carcinoma on the Liver Transplant Waitlist. Gastroenterology. 2025 Apr; 168 (4):784-794.e4 Epub 2024 Nov 30
    View PubMed
  5. Norman JS, Mehta N, Kim WR, Liang JW, Biggins SW, Asrani SK, Heimbach J, Charu V, Kwong AJ. Model of urgency for liver transplantation in hepatocellular carcinoma: a practical model to prioritize patients with hepatocellular carcinoma on the liver transplant waitlist. Gastroenterology. 2025 Apr; 168 (4):784-94.e4
  6. Allen AM, Kim WR, Carrieri P, Canning R, Ou FS, Benson J, Olson JL, Venkatesh SK, Li J, Yin M, Eslami M, Ehman RL, Hunter Berg J, Lazarus JV. Population perspectives on benefits and harms of screening for metabolic dysfunction-associated steatotic liver disease. Hepatology. 2025 Mar 19 [Epub ahead of print]
    View PubMed
  7. Kim WR, Mannalithara A, Charu V, Chung N, Kwong A, Kwo PY, Torok NJ, Asch SM, Kim SH. Optimal Population Screening Strategies for Liver Fibrosis Associated With Metabolic Dysfunction-Associated Steatotic Liver Disease. Am J Gastroenterol. 2025 Jan 3 Epub 2025 Jan 03
    View PubMed
  8. Chen VL, Morgan TR, Rotman Y, Patton HM, Cusi K, Kanwal F, Kim WR. Resmetirom therapy for metabolic dysfunction-associated steatotic liver disease: October 2024 updates to AASLD Practice Guidance. Hepatology. 2025 Jan 1; 81 (1):312-320 Epub 2024 Oct 18
    View PubMed
  9. Sedki M, Kim WR, Kwong A, Charu V, Sripongpun P, Mannalithara A. Steatotic liver disease in the US: the impact of the new nomenclature on classification of subjects with metabolic dysfunction-associated steatotic liver disease and alcohol-associated liver disease. Gastro Hep Advances. 2025; 4 (5):100629
  10. Sripongpun P, Kaewdech A, Udompap P, Kim WR. Characteristics and long-term mortality of individuals with MASLD, MetALD, and ALD, and the utility of SAFE score. JHEP Rep. 2024 Oct; 6 (10):101127 Epub 2024 June 03
    View PubMed
  11. Ferguson Toll J, Sola E, Perez MA, Piano S, Cheng A, Subramanian AK, Kim WR. Infections in decompensated cirrhosis: Pathophysiology, management, and research agenda. Hepatol Commun. 2024 Oct 1; 8 (10) Epub 2024 Oct 03
    View PubMed
  12. Mayo MJ, Carey E, Smith HT, Mospan AR, McLaughlin M, Thompson A, Morris HL, Sandefur R, Kim WR, Bowlus C, Levy C, TARGET-PBC Investigators. Correction to: Impact of Pruritus on Quality of Life and Current Treatment Patterns in Patients with Primary Biliary Cholangitis. Dig Dis Sci. 2023 Oct; 68 (10):4064-4065
    View PubMed
  13. Sripongpun P, Udompap P, Mannalithara A, Downing NL, Vidovszky AA, Kwong AJ, Goel A, Kwo PY, Kim WR. Hepatitis C Screening in Post-Baby Boomer Generation Americans: One Size Does Not Fit All. Mayo Clin Proc. 2023 Sep; 98 (9):1335-1344
    View PubMed
  14. Lim YS, Kim WR, Dieterich D, Kao JH, Flaherty JF, Yee LJ, Roberts LR, Razavi H, Kennedy PTF. Evidence for Benefits of Early Treatment Initiation for Chronic Hepatitis B. Viruses. 2023 Apr 18; 15 (4)
    View PubMed
  15. Mayo MJ, Carey E, Smith HT, Mospan AR, McLaughlin M, Thompson A, Morris HL, Sandefur R, Kim WR, Bowlus C, Levy C, TARGET-PBC Investigators. Impact of Pruritus on Quality of Life and Current Treatment Patterns in Patients with Primary Biliary Cholangitis. Dig Dis Sci. 2023 Mar; 68 (3):995-1005 Epub 2022 June 15
    View PubMed
  16. Halket D, Dang J, Phadke A, Jayasekera C, Kim WR, Kwo P, Downing L, Goel A. Targeted Electronic Patient Portal Messaging Increases Hepatitis C Virus Screening in Primary Care: a Randomized Study. J Gen Intern Med. 2022 Oct; 37 (13):3318-3324 Epub 2022 Mar 01
    View PubMed
  17. Singal AK, Kwo P, Kwong A, Liangpunsakul S, Louvet A, Mandrekar P, McClain C, Mellinger J, Szabo G, Terrault N, Thursz M, Winder GS, Kim WR, Shah VH. Research methodologies to address clinical unmet needs and challenges in alcohol-associated liver disease. Hepatology. 2022 Apr; 75 (4):1026-1037 Epub 2021 Nov 27
    View PubMed
  18. Duarte-Rojo A, Heimbach JK, Borja-Cacho D, Barone GW, Shaheen MF, Lamps LW, Graham RP, Tan EK, Concepcion W, Kim WR. Usefulness of Controlled Attenuation Parameter and Liver Stiffness Measurement for the Identification of Extended-criteria Donors and Risk-assessment in Liver Transplantation. Transplantation. 2022 Feb 1; 106 (2):318-327
    View PubMed
  19. Kim WR, Mannalithara A, Heimbach JK, Kamath PS, Asrani SK, Biggins SW, Wood NL, Gentry SE, Kwong AJ. MELD 3.0: The Model for End-Stage Liver Disease Updated for the Modern Era. Gastroenterology. 2021 Dec; 161 (6):1887-1895.e4 Epub 2021 Sept 03
    View PubMed
  20. Kwong AJ, Kim WR, Lake JR, Smith JM, Schladt DP, Skeans MA, Noreen SM, Foutz J, Booker SE, Cafarella M, Snyder JJ, Israni AK, Kasiske BL. OPTN/SRTR 2019 Annual Data Report: Liver. Am J Transplant. 2021 Feb; 21 Suppl 2:208-315
    View PubMed
  21. Asrani SK, Jennings LW, Kim WR, Kamath PS, Levitsky J, Nadim MK, Testa G, Leise MD, Trotter JF, Klintmalm G. MELD-GRAIL-Na: Glomerular Filtration Rate and Mortality on Liver-Transplant Waiting List. Hepatology. 2020 May; 71 (5):1766-1774 Epub 2020 Jan 29
    View PubMed
  22. Udompap P, Kim WR. Development of Hepatocellular Carcinoma in Patients With Suppressed Viral Replication: Changes in Risk Over Time. Clin Liver Dis (Hoboken). 2020 Feb; 15 (2):85-90 Epub 2020 Mar 26
    View PubMed
  23. Kim WR. Overview of Current and Emerging Treatments for Hepatitis B Virus Infection. Gastroenterol Hepatol (N Y). 2020 Feb; 16 (2):95-97
    View PubMed
  24. Kwong A, Kim WR, Lake JR, Smith JM, Schladt DP, Skeans MA, Noreen SM, Foutz J, Miller E, Snyder JJ, Israni AK, Kasiske BL. OPTN/SRTR 2018 Annual Data Report: Liver. Am J Transplant. 2020 Jan; 20 Suppl s1:193-299
    View PubMed
  25. Wang JH, Gustafson SK, Skeans MA, Lake JR, Kim WR, Kasiske BL, Israni AK, Hart A. OPTN/SRTR 2018 Annual Data Report: Hepatitis C. Am J Transplant. 2020 Jan; 20 Suppl s1:542-568
    View PubMed
  26. Kwong AJ, Mannalithara A, Heimbach J, Prentice MA, Kim WR. Migration of Patients for Liver Transplantation and Waitlist Outcomes. Clin Gastroenterol Hepatol. 2019 Oct; 17 (11):2347-2355.e5 Epub 2019 May 08
    View PubMed
  27. Kim S, Kwon SH, Kam TI, Panicker N, Karuppagounder SS, Lee S, Lee JH, Kim WR, Kook M, Foss CA, Shen C, Lee H, Kulkarni S, Pasricha PJ, Lee G, Pomper MG, Dawson VL, Dawson TM, Ko HS. Transneuronal Propagation of Pathologic alpha-Synuclein from the Gut to the Brain Models Parkinson's Disease. Neuron. 2019 Aug 21; 103 (4):627-641.e7 Epub 2019 June 26
    View PubMed
  28. Wijarnpreecha K, Scribani M, Kim D, Kim WR. The interaction of nonalcoholic fatty liver disease and smoking on mortality among adults in the United States. Liver Int. 2019 Jul; 39 (7):1202-1206 Epub 2019 Mar 13
    View PubMed
  29. Kim WR, Lake JR, Smith JM, Schladt DP, Skeans MA, Noreen SM, Robinson AM, Miller E, Snyder JJ, Israni AK, Kasiske BL. OPTN/SRTR 2017 Annual Data Report: Liver. Am J Transplant. 2019 Feb; 19 Suppl 2:184-283
    View PubMed
  30. Udompap P, Kim D, Ahmed A, Kim WR. Longitudinal trends in renal function in chronic hepatitis B patients receiving oral antiviral treatment. Aliment Pharmacol Ther. 2018 Dec; 48 (11-12):1282-1289 Epub 2018 Oct 29
    View PubMed
  31. Allen AM, Heimbach JK, Larson JJ, Mara KC, Kim WR, Kamath PS, Therneau TM. Reduced Access to Liver Transplantation in Women: Role of Height, MELD Exception Scores, and Renal Function Underestimation. Transplantation. 2018 Oct; 102 (10):1710-1716
    View PubMed
  32. Goel A, Kim WR. Natural History of Primary Biliary Cholangitis in the Ursodeoxycholic Acid Era: Role of Scoring Systems. Clin Liver Dis. 2018 Aug; 22 (3):563-578
    View PubMed
  33. Yang JD, Mannalithara A, Piscitello AJ, Kisiel JB, Gores GJ, Roberts LR, Kim WR. Impact of surveillance for hepatocellular carcinoma on survival in patients with compensated cirrhosis. Hepatology. 2018 Jul; 68 (1):78-88 Epub 2018 May 09
    View PubMed
  34. Kim WR. Emerging Therapies Toward a Functional Cure for Hepatitis B Virus Infection. Gastroenterol Hepatol (N Y). 2018 Jul; 14 (7):439-442
    View PubMed
  35. Kwong A, Kim WR, Mannalithara A, Heo NY, Udompap P, Kim D. Decreasing mortality and disease severity in hepatitis C patients awaiting liver transplantation in the United States. Liver Transpl. 2018 Jun; 24 (6):735-743 Epub 2018 Mar 25
    View PubMed
  36. Levy C, Bowlus CL, Carey E, Crawford JM, Deane K, Mayo MJ, Kim WR, Fried MW. A real-world observational cohort of patients with primary biliary cholangitis: TARGET-primary biliary cholangitis study design and rationale. Hepatol Commun. 2018 May; 2 (5):484-491 Epub 2018 Mar 23
    View PubMed
  37. Siegel DH, Cottrell CE, Streicher JL, Schilter KF, Basel DG, Baselga E, Burrows PE, Ciliberto HM, Vigh-Conrad KA, Eichenfield LF, Holland KE, Hogeling M, Jensen JN, Kelly ME, Kim W, King DM, McCuaig C, Mueller KA, Pope E, Powell J, Price H, Steiner JE, Frieden IJ, Tollefson MM, Drolet BA. Analyzing the Genetic Spectrum of Vascular Anomalies with Overgrowth via Cancer Genomics. J Invest Dermatol. 2018 Apr; 138 (4):957-967 Epub 2017 Nov 22
    View PubMed
  38. Heo NY, Mannalithara A, Kim D, Udompap P, Tan JC, Kim WR. Long-term Patient and Graft Survival of Kidney Transplant Recipients With Hepatitis C Virus Infection in the United States. Transplantation. 2018 Mar; 102 (3):454-460
    View PubMed
  39. Kim WR, Lake JR, Smith JM, Schladt DP, Skeans MA, Harper AM, Wainright JL, Snyder JJ, Israni AK, Kasiske BL. OPTN/SRTR 2016 Annual Data Report: Liver. Am J Transplant. 2018 Jan; 18 Suppl 1:172-253
    View PubMed
  40. Kim SG, Larson JJ, Lee JS, Therneau TM, Kim WR. Beneficial and harmful effects of nonselective beta blockade on acute kidney injury in liver transplant candidates. Liver Transpl. 2017 Jun; 23 (6):733-740
    View PubMed
  41. Hassan MA, Kim WR, Smith CI, Fried MW, Sterling RK, Ghany MG, Wahed AS, Ganova-Raeva LM, Roberts LR, Lok ASF. Characteristics of US-born versus foreign-born Americans of African descent with chronic Hepatitis B American Journal of Epidemiology. 2017; 186: (3)356-66.
  42. Allen AM, Kim WR, Moriarty JP, Shah ND, Larson JJ, Kamath PS. Time trends in the health care burden and mortality of acute on chronic liver failure in the United States. Hepatology. 2016 Dec; 64 (6):2165-2172 Epub 2016 Oct 20
    View PubMed
  43. Garzon MC, Epstein LG, Heyer GL, Frommelt PC, Orbach DB, Baylis AL, Blei F, Burrows PE, Chamlin SL, Chun RH, Hess CP, Joachim S, Johnson K, Kim W, Liang MG, Maheshwari M, McCoy GN, Metry DW, Monrad PA, Pope E, Powell J, Shwayder TA, Siegel DH, Tollefson MM, Vadivelu S, Lew SM, Frieden IJ, Drolet BA. PHACE Syndrome: Consensus-Derived Diagnosis and Care Recommendations. J Pediatr. 2016 Nov; 178:24-33.e2 Epub 2016 Sept 19
    View PubMed
  44. Yang JD, Mohamed HA, Ahmed Mohammed H, Cvinar JL, Gores GJ, Roberts LR, Kim WR. Diabetes Mellitus Heightens the Risk of Hepatocellular Carcinoma Except in Patients With Hepatitis C Cirrhosis. Am J Gastroenterol. 2016 Nov; 111 (11):1573-1580 Epub 2016 Aug 16
    View PubMed
  45. Zhang Z, Smischney NJ, Zhang H, Van Poucke S, Tsirigotis P, Rello J, Honore PM, Sen Kuan W, Ray JJ, Zhou J, Shang Y, Yu Y, Jung C, Robba C, Taccone FS, Caironi P, Grimaldi D, Hofer S, Dimopoulos G, Leone M, Hong SB, Bahloul M, Argaud L, Kim WY, Spapen HD, Rocco JR. AME evidence series 001-The Society for Translational Medicine: clinical practice guidelines for diagnosis and early identification of sepsis in the hospital. J Thorac Dis. 2016 Sep; 8 (9):2654-2665
    View PubMed
  46. Wi CI, Kim WR, Gross JB, Stadheim LM, Poterucha JJ. Potential Efficacy of Pegylated Interferon-alpha and a Nucleos(t)ide Analogue as Combination Therapy for HBeAg-Positive Chronic Hepatitis B. Gut Liver. 2016 Jul 16; 10 (4):611-6
    View PubMed
  47. Allen AM, Kim WR. Epidemiology and Healthcare Burden of Acute-on-Chronic Liver Failure. Semin Liver Dis. 2016 May; 36 (2):123-6 Epub 2016 May 12
    View PubMed
  48. Udompap P, Mannalithara A, Heo NY, Kim D, Kim WR. Increasing prevalence of cirrhosis among U.S. adults aware or unaware of their chronic hepatitis C virus infection. J Hepatol. 2016 May; 64 (5):1027-1032 Epub 2016 Jan 22
    View PubMed
  49. Park JJ, Wong DK, Wahed AS, Lee WM, Feld JJ, Terrault N, Khalili M, Sterling RK, Kowdley KV, Bzowej N, Lau DT, Kim WR, Smith C, Carithers RL, Torrey KW, Keith JW, Levine DL, Traum D, Ho S, Valiga ME, Johnson GS, Doo E, Lok AS, Chang KM, Hepatitis B Research Network. Hepatitis B Virus--Specific and Global T-Cell Dysfunction in Chronic Hepatitis B. Gastroenterology. 2016 Mar; 150 (3):684-695.e5 Epub 2015 Dec 10
    View PubMed
  50. Allen AM, Kim WR, Larson JJ, Rosedahl JK, Yawn BP, McKeon K, Hay JE. The Epidemiology of Liver Diseases Unique to Pregnancy in a US Community: A Population-Based Study. Clin Gastroenterol Hepatol. 2016 Feb; 14 (2):287-94.e1-2 Epub 2015 Aug 21
    View PubMed
  51. Udompap P, Kim D, Kim WR. Current and Future Burden of Chronic Nonmalignant Liver Disease. Clin Gastroenterol Hepatol. 2015 Nov; 13 (12):2031-41 Epub 2015 Aug 17
    View PubMed
  52. Kim WR, Loomba R, Berg T, Aguilar Schall RE, Yee LJ, Dinh PV, Flaherty JF, Martins EB, Therneau TM, Jacobson I, Fung S, Gurel S, Buti M, Marcellin P. Impact of long-term tenofovir disoproxil fumarate on incidence of hepatocellular carcinoma in patients with chronic hepatitis B. Cancer. 2015 Oct 15; 121: (20)3631-8.
    View PubMed
  53. Allen AM, Kim WR, Larson JJ, Colby C, Therneau TM, Rule AD. Serum Cystatin C as an Indicator of Renal Function and Mortality in Liver Transplant Recipients. Transplantation. 2015 Jul; 99 (7):1431-5
    View PubMed
  54. Heimbach JK, Hirose R, Stock PG, Schladt DP, Xiong H, Liu J, Olthoff KM, Harper A, Snyder JJ, Israni AK, Kasiske BL, Kim WR. Delayed hepatocellular carcinoma model for end-stage liver disease exception score improves disparity in access to liver transplant in the United States. Hepatology. 2015 May; 61 (5):1643-50 Epub 2015 Feb 24
    View PubMed
  55. Wi CI, Loo NM, Larson JJ, Moynihan TJ, Madde NR, Grendahl DC, Alberts SR, Kim WR. Low level of hepatitis B virus screening among patients receiving chemotherapy. Clin Gastroenterol Hepatol. 2015 May; 13 (5):970-5; quiz e51 Epub 2014 Nov 06
    View PubMed
  56. Khalili M, Lombardero M, Chung RT, Terrault NA, Ghany MG, Kim WR, Lau D, Lisker-Melman M, Sanyal A, Lok AS, Roberts LR, Smith CI, Di BAM, Brunt EM, Janssen HLA, Wong DK, Juan J, Feld J, Yim C, Heathcote J, Lee WM, Perrillo R, Do S, Han SHB, Tran TT, Cooper SL, Fontana RJ, Tsai N, Fried MW, Patel K, Evon D, Carithers RC, Shuhart M, Kowdley KV, Wang CC, Sterling RK, Jake LT, Chang KM, Park JJ, Belle S, Wahed A, Cloonan Y, Kleiner D. Diabetes and prediabetes in patients with hepatitis B residing in North America. Hepatology. 2015; 62(5):1364-74.
    View PubMed
  57. Ghany MG, Perrillo R, Li R, Belle SH, Janssen HLA, Terrault NA, Shuhart MC, Lau DTY, Kim WR, Fried MW, Sterling RK, Di Bisceglie AM, Han SHB, Ganova-Raeva LM, Chang KM, Lok ASF, Chung RT, Roberts LR, Smith CI, Lisker-Melman M, Wong DK, Juan J, Feld J, Yim C, Heathcoate J, Lee WM, Do S, Tran TT, Khalili M, Cooper SL, Fontana RJ, Tsai N, Patel K, Evon D, Carithers RC, Kowdley KV, Wang CC, Liang TJ, Park JJ, Wahed A, Kleiner D, Afdhal N, Javaid A, Niu J, Han J, Nasser I, Stahler AC, Stadheim L, Hassan M, King DL, Nagy RA, La D, Liu L, Minshall S, Bass S, French S, Peacock V, Ungermann A, Ayala C, Olson E, Lau I, Podolskaya V, DeVole N, McKenna B, Oberhelman K, Kaza S, Rodd C, Huddleston L, Poerzgen P, Darling JM, Barritt AS, Marsh T, Metheny V, Cardona D, Luketic VA, Smith PG, Hofmann C, Mathisen T, Strom S, Mooney J, Cardona-Gonzalez L, Fryzek N, Rivera E, Morris N, Haynes-Williams V, Valiga ME, Torrey K, Levine D, Keith J, Betts M, Montaner LJ, Teo CG, Khudyakov Y, Punkova LT, Cloonan Y, Danielson M, Haller T, Johnson G, Kelley S, Lawlor S, Lombardero M, MacGregor JM, Pelesko A, Stoliker D, Walters B, Zadorozny E. Characteristics of adults in the hepatitis B research network in North America reflect their country of origin and hepatitis B virus genotype. Clin Gastroenterol Hepatol. 2015; 13(1):183-92.
    View PubMed
  58. Kim WR, Lake JR, Smith JM, Skeans MA, Schladt DP, Edwards EB, Harper AM, Wainright JL, Snyder JJ, Israni AK, Kasiske BL. OPTN/SRTR 2013 Annual Data Report: liver. Am J Transplant. 2015 Jan; 15 Suppl 2:1-28
    View PubMed
  59. Zhang X, Harmsen WS, Mettler TA, Kim WR, Roberts RO, Therneau TM, Roberts LR, Chaiteerakij R. Continuation of metformin use after a diagnosis of cirrhosis significantly improves survival of patients with diabetes. Hepatology. 2014 Dec; 60 (6):2008-16 Epub 2014 July 31
    View PubMed
  60. Allen AM, Kim WR, Therneau TM, Larson JJ, Heimbach JK, Rule AD. Chronic kidney disease and associated mortality after liver transplantation--a time-dependent analysis using measured glomerular filtration rate. J Hepatol. 2014 Aug; 61 (2):286-92 Epub 2014 Apr 05
    View PubMed
  61. Leise MD, Yun BC, Larson JJ, Benson JT, Yang JD, Therneau TM, Rosen CB, Heimbach JK, Biggins SW, Kim WR. Effect of the pretransplant serum sodium concentration on outcomes following liver transplantation. Liver Transpl. 2014 Jun; 20 (6):687-97
    View PubMed
  62. Al-Bawardy B, Kim WR, Poterucha JJ, Gross JB, Charlton MR, Larson JJ, Colby CL, Canterbury K, Warner J, Therneau TM. Comparative effectiveness of telaprevir-based triple therapy in patients with chronic hepatitis C. Mayo Clin Proc. 2014 May; 89 (5):595-601 Epub 2014 Mar 21
    View PubMed
  63. Allen AM, Kim WR, Xiong H, Liu J, Stock PG, Lake JR, Chinnakotla S, Snyder JJ, Israni AK, Kasiske BL. Survival of recipients of livers from donation after circulatory death who are relisted and undergo retransplant for graft failure. Am J Transplant. 2014 May; 14 (5):1120-8 Epub 2014 Apr 14
    View PubMed
  64. Younossi ZM, Kanwal F, Saab S, Brown KA, El-Serag HB, Kim WR, Ahmed A, Kugelmas M, Gordon SC. The impact of hepatitis C burden: an evidence-based approach. Aliment Pharmacol Ther. 2014 Mar; 39(5):518-31. Epub 2014 Jan 26.
    View PubMed
  65. Leise MD, Poterucha JJ, Kamath PS, Kim WR. Management of hepatic encephalopathy in the hospital. Mayo Clin Proc. 2014 Feb; 89 (2):241-53 Epub 2014 Jan 08
    View PubMed
  66. Kim WR, Smith JM, Skeans MA, Schladt DP, Schnitzler MA, Edwards EB, Harper AM, Wainright JL, Snyder JJ, Israni AK, Kasiske BL. OPTN/SRTR 2012 Annual Data Report: liver. Am J Transplant. 2014 Jan; 14 Suppl 1:69-96
    View PubMed
  67. Kim BH, Park JW, Nam BH, Kwak HW, Kim WR. Validation of a model to estimate survival in ambulatory patients with hepatocellular carcinoma: A single-centre cohort study. Liver Int. 2014; 34(7):e317-23.
    View PubMed
  68. Allen AM, Kim WR, Larson J, Loftus EV Jr. Efficacy and safety of treatment of hepatitis C in patients with inflammatory bowel disease. Clin Gastroenterol Hepatol. 2013 Dec; 11 (12):1655-60.e1 Epub 2013 July 23
    View PubMed
  69. Asrani SK, Kim WR, Edwards EB, Larson JJ, Thabut G, Kremers WK, Therneau TM, Heimbach J. Impact of the center on graft failure after liver transplantation. Liver Transpl. 2013 Sep; 19 (9):957-64 Epub 2013 July 26
    View PubMed
  70. Hussaini SM, Jun H, Cho CH, Kim HJ, Kim WR, Jang MH. Heat-induced antigen retrieval: an effective method to detect and identify progenitor cell types during adult hippocampal neurogenesis. J Vis Exp. 2013 Aug 30; (78)
    View PubMed
  71. Asrani SK, Larson JJ, Yawn B, Therneau TM, Kim WR. Underestimation of liver-related mortality in the United States. Gastroenterology. 2013 Aug; 145 (2):375-82.e1-2 Epub 2013 Apr 09
    View PubMed
  72. Kim D, Kim WR, Talwalkar JA, Kim HJ, Ehman RL. Advanced fibrosis in nonalcoholic fatty liver disease: noninvasive assessment with MR elastography. Radiology. 2013 Aug; 268 (2):411-9 Epub 2013 Apr 05
    View PubMed
  73. Chu D, Yang JD, Lok AS, Tran T, Martins EB, Fagan E, Rousseau F, Kim WR. Hepatitis B screening and vaccination practices in asian american primary care. Gut Liver. 2013 Jul; 7(4):450-7. Epub 2013 Jun 11.
    View PubMed
  74. Darwish Murad S, Heimbach JK, Gores GJ, Rosen CB, Benson JT, Kim WR. Excellent quality of life after liver transplantation for patients with perihilar cholangiocarcinoma who have undergone neoadjuvant chemoradiation. Liver Transpl. 2013 May; 19 (5):521-8 Epub 2013 Apr 09
    View PubMed
  75. Kim D, Kim WR, Kim HJ, Therneau TM. Association between noninvasive fibrosis markers and mortality among adults with nonalcoholic fatty liver disease in the United States. Hepatology. 2013 Apr; 57 (4):1357-65 Epub 2013 Jan 25
    View PubMed
  76. Chaiteerakij R, Yang JD, Harmsen WS, Slettedahl SW, Mettler TA, Fredericksen ZS, Kim WR, Gores GJ, Roberts RO, Olson JE, Therneau TM, Roberts LR. Risk factors for intrahepatic cholangiocarcinoma: association between metformin use and reduced cancer risk. Hepatology. 2013 Feb; 57 (2):648-55 Epub 2012 Dec 12
    View PubMed
  77. Kim WR, Stock PG, Smith JM, Heimbach JK, Skeans MA, Edwards EB, Harper AM, Snyder JJ, Israni AK, Kasiske BL. OPTN/SRTR 2011 Annual Data Report: liver. Am J Transplant. 2013 Jan; 13 Suppl 1:73-102.
    View PubMed
  78. Smith JM, Biggins SW, Haselby DG, Kim WR, Wedd J, Lamb K, Thompson B, Segev DL, Gustafson S, Kandaswamy R, Stock PG, Matas AJ, Samana CJ, Sleeman EF, Stewart D, Harper A, Edwards E, Snyder JJ, Kasiske BL, Israni AK. Kidney, pancreas and liver allocation and distribution in the United States. Am J Transplant. 2012 Dec; 12(12):3191-212. Epub 2012 Nov 16.
    View PubMed
  79. Nadim MK, Sung RS, Davis CL, Andreoni KA, Biggins SW, Danovitch GM, Feng S, Friedewald JJ, Hong JC, Kellum JA, Kim WR, Lake JR, Melton LB, Pomfret EA, Saab S, Genyk YS. Simultaneous liver-kidney transplantation summit: current state and future directions. Am J Transplant. 2012 Nov; 12(11):2901-8. Epub 2012 Jul 23.
    View PubMed
  80. Darwish Murad S, Kim WR, Therneau T, Gores GJ, Rosen CB, Martenson JA, Alberts SR, Heimbach JK. Predictors of pretransplant dropout and posttransplant recurrence in patients with perihilar cholangiocarcinoma. Hepatology. 2012 Sep; 56 (3):972-81 Epub 2012 July 17
    View PubMed
  81. Kim D, Choi SY, Park EH, Lee W, Kang JH, Kim W, Kim YJ, Yoon JH, Jeong SH, Lee DH, Lee HS, Larson J, Therneau TM, Kim WR. Nonalcoholic fatty liver disease is associated with coronary artery calcification. Hepatology. 2012 Aug; 56(2):605-13. Epub 2012 Jul 02.
    View PubMed
  82. Yang JD, Kim B, Sanderson SO, Sauver JS, Yawn BP, Larson JJ, Therneau TM, Roberts LR, Gores GJ, Kim WR. Biliary tract cancers in Olmsted County, Minnesota, 1976-2008. Am J Gastroenterol. 2012 Aug; 107(8):1256-62. Epub 2012 Jul 03.
    View PubMed
  83. Yang JD, Kim WR, Park KW, Chaiteerakij R, Kim B, Sanderson SO, Larson JJ, Pedersen RA, Therneau TM, Gores GJ, Roberts LR, Park JW. Model to estimate survival in ambulatory patients with hepatocellular carcinoma. Hepatology. 2012 Aug; 56 (2):614-21 Epub 2012 July 02
    View PubMed
  84. Darwish Murad S, Kim WR, Harnois DM, Douglas DD, Burton J, Kulik LM, Botha JF, Mezrich JD, Chapman WC, Schwartz JJ, Hong JC, Emond JC, Jeon H, Rosen CB, Gores GJ, Heimbach JK. Efficacy of neoadjuvant chemoradiation, followed by liver transplantation, for perihilar cholangiocarcinoma at 12 US centers. Gastroenterology. 2012 Jul; 143 (1):88-98.e3; quiz e14 Epub 2012 Apr 12
    View PubMed
  85. Kim JY, Asrani SK, Shah ND, Kim WR, Schneekloth TD. Hospitalization for underage drinkers in the United States. J Adolesc Health. 2012 Jun; 50 (6):648-50 Epub 2012 Feb 14
    View PubMed
  86. Lee TH, Kim WR, Poterucha JJ. Evaluation of elevated liver enzymes. Clin Liver Dis. 2012 May; 16(2):183-98.
    View PubMed
  87. Akkina SK, Asrani SK, Peng Y, Stock P, Kim WR, Israni AK. Development of organ-specific donor risk indices. Liver Transpl. 2012 Apr; 18(4):395-404.
    View PubMed
  88. Adebajo CO, Talwalkar JA, Poterucha JJ, Kim WR, Charlton MR. Ultrasound-based transient elastography for the detection of hepatic fibrosis in patients with recurrent hepatitis C virus after liver transplantation: a systematic review and meta-analysis. Liver Transpl. 2012 Mar; 18 (3):323-31
    View PubMed
  89. Yang JD, Kim B, Sanderson SO, St Sauver JL, Yawn BP, Pedersen RA, Larson JJ, Therneau TM, Roberts LR, Kim WR. Hepatocellular carcinoma in olmsted county, Minnesota, 1976-2008. Mayo Clin Proc. 2012 Jan; 87 (1):9-16
    View PubMed
  90. Ward JW, Lok AS, Thomas DL, El-Serag HB, Kim WR. Report on a single-topic conference on "Chronic viral hepatitis--strategies to improve effectiveness of screening and treatment". Hepatology. 2012 Jan; 55(1):307-15.
    View PubMed
  91. Yang JD, Kim WR. Surveillance for hepatocellular carcinoma in patients with cirrhosis. Clin Gastroenterol Hepatol. 2012 Jan; 10(1):16-21. Epub 2011 Jun 13.
    View PubMed
  92. Asrani SK, Kim WR. Model for end-stage liver disease: end of the first decade. Clin Liver Dis. 2011 Nov; 15 (4):685-98 Epub 2011 Oct 01
    View PubMed
  93. Leise MD, Kim WR, Canterbury KM, Poterucha JJ. Drug therapy: telaprevir. Hepatology. 2011 Oct; 54(4):1463-9.
    View PubMed
  94. Yang JD, Harmsen WS, Slettedahl SW, Chaiteerakij R, Enders FT, Therneau TM, Orsini L, Kim WR, Roberts LR. Factors that affect risk for hepatocellular carcinoma and effects of surveillance. Clin Gastroenterol Hepatol. 2011 Jul; 9(7):617-23.e1. Epub 2011 Apr 01.
    View PubMed
  95. Duarte-Rojo A, Kamath PS, Kim WR. Born to be wild or just confused? Genetic predisposition to hepatic encephalopathy. Gastroenterology. 2011 Jun; 140(7):2137-8. Epub 2011 Apr 24.
    View PubMed
  96. Leise MD, Kim WR, Kremers WK, Larson JJ, Benson JT, Therneau TM. A revised model for end-stage liver disease optimizes prediction of mortality among patients awaiting liver transplantation. Gastroenterology. 2011 Jun; 140 (7):1952-60 Epub 2011 Feb 18
    View PubMed
  97. Sinakos E, Saenger AK, Keach J, Kim WR, Lindor KD. Many patients with primary sclerosing cholangitis and increased serum levels of carbohydrate antigen 19-9 do not have cholangiocarcinoma. Clin Gastroenterol Hepatol. 2011 May; 9(5):434-9.e1. Epub 2011 Feb 17.
    View PubMed
  98. Elewa U, Sandri AM, Kim WR, Fervenza FC. Treatment of hepatitis B virus-associated nephropathy. Nephron Clin Pract. 2011; 119(1):c41-9; discussion c49. Epub 2011 Jun 15.
    View PubMed
  99. Yang JD, Kim WR, Coelho R, Mettler TA, Benson JT, Sanderson SO, Therneau TM, Kim B, Roberts LR. Cirrhosis is present in most patients with hepatitis B and hepatocellular carcinoma. Clin Gastroenterol Hepatol. 2011 Jan; 9 (1):64-70 Epub 2010 Sept 08
    View PubMed
  100. Yang JD, Kim E, Pedersen RA, Kim WR, Pungpapong S, Roberts LR. Utility of Serum YKL-40 as a Tumor-Specific Marker of Hepatobiliary Malignancies. Gut Liver. 2010 Dec; 4 (4):537-42 Epub 2010 Dec 17
    View PubMed
  101. Kim HJ, Larson JJ, Lim YS, Kim WR, Pedersen RA, Therneau TM, Rosen CB. Impact of MELD on waitlist outcome of retransplant candidates. Am J Transplant. 2010 Dec; 10 (12):2652-7 Epub 2010 Nov 10
    View PubMed
  102. Asrani SK, Leise MD, West CP, Murad MH, Pedersen RA, Erwin PJ, Tian J, Wiesner RH, Kim WR. Use of sirolimus in liver transplant recipients with renal insufficiency: a systematic review and meta-analysis. Hepatology. 2010 Oct; 52 (4):1360-70
    View PubMed
  103. Bambha K, Kim WR, Rosen CB, Pedersen RA, Rys C, Kolbert CP, Cunningham JM, Therneau TM. Endothelial nitric oxide synthase gene variation associated with chronic kidney disease after liver transplant. Mayo Clin Proc. 2010 Sep; 85(9):814-20.
    View PubMed
  104. Asrani SK, Kim WR, Pedersen RA, Charlton MR, Kremers WK, Therneau TM, Rosen CB, Dean PG. Daclizumab induction therapy in liver transplant recipients with renal insufficiency. Aliment Pharmacol Ther. 2010 Sep; 32 (6):776-86 Epub 2010 July 26
    View PubMed
  105. Liu SS, Schneekloth TD, Talwalkar JA, Kim WR, Poterucha JJ, Charlton MR, Wiesner RH, Gross JB. Impact of depressive symptoms and their treatment on completing antiviral treatment in patients with chronic hepatitis C. J Clin Gastroenterol. 2010 Sep; 44 (8):e178-85
    View PubMed
  106. Paula H, Asrani SK, Boetticher NC, Pedersen R, Shah VH, Kim WR. Alcoholic liver disease-related mortality in the United States: 1980-2003. Am J Gastroenterol. 2010 Aug; 105 (8):1782-7 Epub 2010 Feb 23
    View PubMed
  107. Matiello M, Kim HJ, Kim W, Brum DG, Barreira AA, Kingsbury DJ, Plant GT, Adoni T, Weinshenker BG. Familial neuromyelitis optica. Neurology. 2010 Jul 27; 75 (4):310-5
    View PubMed
  108. Asrani SK, Lim YS, Therneau TM, Pedersen RA, Heimbach J, Kim WR. Donor race does not predict graft failure after liver transplantation. Gastroenterology. 2010 Jun; 138 (7):2341-7 Epub 2010 Feb 19
    View PubMed
  109. Asrani SK, Kim WR. Organ allocation for chronic liver disease: model for end-stage liver disease and beyond. Curr Opin Gastroenterol. 2010 May; 26 (3):209-13
    View PubMed
  110. Lim YS, Larson TS, Benson JT, Kamath PS, Kremers WK, Therneau TM, Kim WR. Serum sodium, renal function, and survival of patients with end-stage liver disease. J Hepatol. 2010 Apr; 52 (4):523-8 Epub 2010 Feb 04
    View PubMed
  111. Lok AS, Kim WR, El-Serag HB, Maddrey WC. Overview of the viral hepatitis problem. J Fam Pract. 2010 Apr; 59(4 Suppl):S11-6.
    View PubMed
  112. Kim WR, Ward JW, Cheever LW, Dan C, Dee L, Zola J. Transforming the current infrastructure for combating HBV and HCV infections. J Fam Pract. 2010 Apr; 59 (4 Suppl):S65-70
    View PubMed
  113. Kim WR, Valdiserri RO, Wright LN, Manos MM, Do ST. Reports from today's health care environment on the implementation of screening, diagnosis, and treatment recommendations. J Fam Pract. 2010 Apr; 59(4 Suppl):S43-50.
    View PubMed
  114. Kim WR, Terrault NA, Pedersen RA, Therneau TM, Edwards E, Hindman AA, Brosgart CL. Trends in waiting list registration for liver transplantation for viral hepatitis in the United States. Gastroenterology. 2009 Nov; 137 (5):1680-6 Epub 2009 July 24
    View PubMed
  115. Rubio-Tapia A, Kyle RA, Kaplan EL, Johnson DR, Page W, Erdtmann F, Brantner TL, Kim WR, Phelps TK, Lahr BD, Zinsmeister AR, Melton LJ 3rd, Murray JA. Increased prevalence and mortality in undiagnosed celiac disease. Gastroenterology. 2009 Jul; 137 (1):88-93 Epub 2009 Apr 10
    View PubMed
  116. Kim WR. Epidemiology of hepatitis B in the United States. Hepatology. 2009 May; 49 (5 Suppl):S28-34
    View PubMed
  117. Yun BC, Kim WR, Benson JT, Biggins SW, Therneau TM, Kremers WK, Rosen CB, Klintmalm GB. Impact of pretransplant hyponatremia on outcome following liver transplantation. Hepatology. 2009 May; 49 (5):1610-5
    View PubMed
  118. Kamath PS, Kim WR. The international normalized ratio of prothrombin time in the model for end-stage liver disease score: a reliable measure. Clin Liver Dis. 2009 Feb; 13 (1):63-66
    View PubMed
  119. Lim YS, Kim WR. The global impact of hepatic fibrosis and end-stage liver disease. Clin Liver Dis. 2008 Nov; 12 (4):733-46, vii
    View PubMed
  120. Kim WR, Biggins SW, Kremers WK, Wiesner RH, Kamath PS, Benson JT, Edwards E, Therneau TM. Hyponatremia and mortality among patients on the liver-transplant waiting list. N Engl J Med. 2008 Sep 4; 359 (10):1018-26
    View PubMed
  121. Bambha K, Kim WR, Pedersen R, Bida JP, Kremers WK, Kamath PS. Predictors of early re-bleeding and mortality after acute variceal haemorrhage in patients with cirrhosis. Gut. 2008 Jun; 57 (6):814-20 Epub 2008 Feb 04
    View PubMed
  122. Kim WR, Flamm SL, Di Bisceglie AM, Bodenheimer HC, Public Policy Committee of the American Association for the Study of Liver Disease. Serum activity of alanine aminotransferase (ALT) as an indicator of health and disease. Hepatology. 2008 Apr; 47 (4):1363-70
    View PubMed
  123. Mendes FD, Kim WR, Pedersen R, Therneau T, Lindor KD. Mortality attributable to cholestatic liver disease in the United States. Hepatology. 2008 Apr; 47(4):1241-7.
    View PubMed
  124. Lee TH, Kim WR, Benson JT, Therneau TM, Melton LJ 3rd. Serum aminotransferase activity and mortality risk in a United States community. Hepatology. 2008 Mar; 47(3):880-7.
    View PubMed
  125. Kim WR. Epidemiology of Hepatitis B in the United States Current Hepatitis B Reports. 2008 Jan; 2: (1)24-9.
  126. Lee TH, Shah N, Pedersen RA, Kremers WK, Rosen CB, Klintmalm GB, Kim WR. Survival after liver transplantation: Is racial disparity inevitable? Hepatology. 2007 Nov; 46 (5):1491-7
    View PubMed
  127. Stewart CA, Malinchoc M, Kim WR, Kamath PS. Hepatic encephalopathy as a predictor of survival in patients with end-stage liver disease. Liver Transpl. 2007 Oct; 13 (10):1366-71
    View PubMed
  128. Pungpapong S, Kim WR, Poterucha JJ. Natural history of hepatitis B virus infection: an update for clinicians. Mayo Clin Proc. 2007 Aug; 82 (8):967-75
    View PubMed
  129. Murad SD, Kim WR, de Groen PC, Kamath PS, Malinchoc M, Valla DC, Janssen HL. Can the model for end-stage liver disease be used to predict the prognosis in patients with Budd-Chiari syndrome? Liver Transpl. 2007 Jun; 13(6):867-74.
    View PubMed
  130. Teh SH, Nagorney DM, Stevens SR, Offord KP, Therneau TM, Plevak DJ, Talwalkar JA, Kim WR, Kamath PS. Risk factors for mortality after surgery in patients with cirrhosis. Gastroenterology. 2007 Apr; 132(4):1261-9.
    View PubMed
  131. Kamath PS, Kim WR, Advanced Liver Disease Study Group. The model for end-stage liver disease (MELD). Hepatology. 2007 Mar; 45 (3):797-805
    View PubMed
  132. Kim WR. Epidemiology of hepatitis B in the United States. Current Hepatitis Reports. 2007; 6(1):3-8.
  133. Biggins SW, Kim WR, Terrault NA, Saab S, Balan V, Schiano T, Benson J, Therneau T, Kremers W, Wiesner R, Kamath P, Klintmalm G. Evidence-based incorporation of serum sodium concentration into MELD. Gastroenterology. 2006 May; 130(6):1652-60.
    View PubMed
  134. Kim WR, Therneau TM, Benson JT, Kremers WK, Rosen CB, Gores GJ, Dickson ER. Deaths on the liver transplant waiting list: an analysis of competing risks. Hepatology. 2006 Feb; 43 (2):345-51
    View PubMed
  135. Kim WR, Gores GJ, Benson JT, Therneau TM, Melton LJ 3rd. Mortality and hospital utilization for hepatocellular carcinoma in the United States. Gastroenterology. 2005 Aug; 129 (2):486-93
    View PubMed
  136. Rongey C, Bambha K, Vanness D, Pedersen RA, Malinchoc M, Therneau TM, Dickson ER, Kim WR. Employment and health insurance in long-term liver transplant recipients. Am J Transplant. 2005 Aug; 5 (8):1901-8
    View PubMed
  137. Kim WR. The use of decision analytic models to inform clinical decision making in the management of hepatocellular carcinoma. Clin Liver Dis. 2005 May; 9(2):225-34.
    View PubMed
  138. Dunn W, Jamil LH, Brown LS, Wiesner RH, Kim WR, Menon KV, Malinchoc M, Kamath PS, Shah V. MELD accurately predicts mortality in patients with alcoholic hepatitis. Hepatology. 2005 Feb; 41 (2):353-8
    View PubMed
  139. Bambha K, Kim WR, Kremers WK, Therneau TM, Kamath PS, Wiesner R, Rosen CB, Thostenson J, Benson JT, Dickson ER. Predicting survival among patients listed for liver transplantation: an assessment of serial MELD measurements. Am J Transplant. 2004 Nov; 4 (11):1798-804
    View PubMed
  140. Kim WR, Poterucha JJ, Benson JT, Therneau TM. The impact of competing risks on the observed rate of chronic hepatitis C progression. Gastroenterology. 2004 Sep; 127(3):749-55.
    View PubMed
  141. Kim WR, Poterucha JJ, Kremers WK, Ishitani MB, Dickson ER. Outcome of liver transplantation for hepatitis B in the United States. Liver Transpl. 2004 Aug; 10 (8):968-74
    View PubMed
  142. Bambha K, Kim WR. Cost-effectiveness analysis and incremental cost-effectiveness ratios: uses and pitfalls. Eur J Gastroenterol Hepatol. 2004 Jun; 16 (6):519-26
    View PubMed
  143. Abdulkarim AS, Petrovic LM, Kim WR, Angulo P, Lloyd RV, Lindor KD. Primary biliary cirrhosis: an infectious disease caused by Chlamydia pneumoniae? J Hepatol. 2004 Mar; 40(3):380-4.
    View PubMed
  144. Kremers WK, van IJperen M, Kim WR, Freeman RB, Harper AM, Kamath PS, Wiesner RH. MELD score as a predictor of pretransplant and posttransplant survival in OPTN/UNOS Status 1 patients. Hepatology. 2004 Mar; 39(3):764-9.
    View PubMed
  145. Kim WR, Benson JT, Therneau TM, Torgerson HA, Yawn BP, Melton LJ. Changing epidemiology of hepatitis B in a U.S. community. Hepatology. 2004 Mar; 39 (3):811-6
    View PubMed
  146. Rocca LG, Yawn BP, Wollan P, Kim WR. Management of patients with hepatitis C in a community population: Diagnosis, discussions, and decisions to treat. Ann Fam Med. 2004 Mar-Apr; 2(2):116-24.
    View PubMed
  147. Geiman TM, Sankpal UT, Robertson AK, Chen Y, Mazumdar M, Heale JT, Schmiesing JA, Kim W, Yokomori K, Zhao Y, Robertson KD. Isolation and characterization of a novel DNA methyltransferase complex linking DNMT3B with components of the mitotic chromosome condensation machinery. Nucleic Acids Res. 2004; 32(9):2716-29. Epub 2004 May 17.
    View PubMed
  148. Bambha K, Kim WR, Talwalkar J, Torgerson H, Benson JT, Therneau TM, Loftus EV Jr, Yawn BP, Dickson ER, Melton LJ 3rd, Melton LJ. Incidence, clinical spectrum, and outcomes of primary sclerosing cholangitis in a United States community. Gastroenterology. 2003 Nov; 125 (5):1364-9
    View PubMed
  149. Talwalkar JA, Kim WR, Rosen CB, Kamath PS, Wiesner RH. Effect of minimal listing criteria on waiting list registration for liver transplantation: a process-outcome analysis. Mayo Clin Proc. 2003 Apr; 78 (4):431-5
    View PubMed
  150. Evans LT, Kim WR, Poterucha JJ, Kamath PS. Spontaneous bacterial peritonitis in asymptomatic outpatients with cirrhotic ascites. Hepatology. 2003 Apr; 37 (4):897-901
    View PubMed
  151. Kim WR. The burden of hepatitis C in the United States. Hepatology. 2002 Nov; 36(5 Suppl 1):S30-4.
    View PubMed
  152. Kim WR. Motion - the available treatments for hepatitis C are cost effective: arguments against the motion. Can J Gastroenterol. 2002 Oct; 16 (10):710-5
    View PubMed
  153. Vanness DJ, Kim WR. Bayesian estimation, simulation and uncertainty analysis: the cost-effectiveness of ganciclovir prophylaxis in liver transplantation. Health Econ. 2002 Sep; 11 (6):551-66
    View PubMed
  154. Kim WR, Brown RS Jr, Terrault NA, El-Serag H. Burden of liver disease in the United States: summary of a workshop. Hepatology. 2002 Jul; 36 (1):227-42
    View PubMed
  155. Yawn BP, Gazzuola L, Wollan PC, Kim WR. Development and maintenance of a community-based hepatitis C registry. Am J Manag Care. 2002 Mar; 8(3):253-61.
    View PubMed
  156. Yawn BP, Wollan P, Gazzuola L, Kim WR. Diagnosis and 10-year follow-up of a community-based hepatitis C cohort. J Fam Pract. 2002 Feb; 51(2):135-40.
    View PubMed
  157. Wiesner RH, McDiarmid SV, Kamath PS, Edwards EB, Malinchoc M, Kremers WK, Krom RA, Kim WR. MELD and PELD: application of survival models to liver allocation. Liver Transpl. 2001 Jul; 7 (7):567-80
    View PubMed
  158. Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, D'Amico G, Dickson ER, Kim WR. A model to predict survival in patients with end-stage liver disease. Hepatology. 2001 Feb; 33 (2):464-70
    View PubMed
  159. Kim WR, Gross JB Jr, Poterucha JJ, Locke GR 3rd, Dickson ER. Outcome of hospital care of liver disease associated with hepatitis C in the United States. Hepatology. 2001 Jan; 33 (1):201-6
    View PubMed
  160. Kim WR, Lindor KD, Locke GR 3rd, Locke GR 3rd, Therneau TM, Homburger HA, Batts KP, Yawn BP, Petz JL, Melton LJ 3rd, Melton LJ 3rd, Dickson ER. Epidemiology and natural history of primary biliary cirrhosis in a US community. Gastroenterology. 2000 Dec; 119 (6):1631-6
    View PubMed
  161. Kim WR, Lindor KD, Malinchoc M, Petz JL, Jorgensen R, Dickson ER. Reliability and validity of the NIDDK-QA instrument in the assessment of quality of life in ambulatory patients with cholestatic liver disease. Hepatology. 2000 Nov; 32 (5):924-9
    View PubMed
  162. Talwalkar JA, Seaberg E, Kim WR, Wiesner RH. Predicting clinical and economic outcomes after liver transplantation using the Mayo primary sclerosing cholangitis model and Child-Pugh score. Liver Transpl. 2000 Nov; 6(6):753-758.
    View PubMed
  163. Kim WR, Therneau TM, Wiesner RH, Poterucha JJ, Benson JT, Malinchoc M, LaRusso NF, Lindor KD, Dickson ER. A revised natural history model for primary sclerosing cholangitis. Mayo Clin Proc. 2000 Jul; 75 (7):688-94
    View PubMed
  164. Kim WR, Krowka MJ, Plevak DJ, Lee J, Rettke SR, Frantz RP, Wiesner RH. Accuracy of Doppler echocardiography in the assessment of pulmonary hypertension in liver transplant candidates. Liver Transpl. 2000 Jul; 6: (4)453-8.
    View PubMed
  165. Kim WR, Wiesner RH, Poterucha JJ, Therneau TM, Benson JT, Krom RA, Dickson ER. Adaptation of the Mayo primary biliary cirrhosis natural history model for application in liver transplant candidates. Liver Transpl. 2000 Jul; 6(4):489-94.
    View PubMed
  166. Kim WR, Ludwig J, Lindor KD. Variant forms of cholestatic diseases involving small bile ducts in adults. Am J Gastroenterol. 2000 May; 95(5):1130-8.
    View PubMed
  167. Kim WR, Badley AD, Wiesner RH, Porayko MK, Seaberg EC, Keating MR, Evans RW, Dickson ER, Krom RA, Paya CV. The economic impact of cytomegalovirus infection after liver transplantation. Transplantation. 2000 Feb 15; 69 (3):357-61
    View PubMed
  168. Kim WR, Wiesner RH, Poterucha JJ, Therneau TM, Malinchoc M, Benson JT, Crippin JS, Klintmalm GB, Rakela J, Starzl TE, Krom RA, Evans RW, Dickson ER. Hepatic retransplantation in cholestatic liver disease: impact of the interval to retransplantation on survival and resource utilization. Hepatology. 1999 Aug; 30(2):395-400.
    View PubMed
  169. Kim WR, Poterucha JJ, Wiesner RH, LaRusso NF, Lindor KD, Petz J, Therneau TM, Malinchoc M, Dickson ER. The relative role of the Child-Pugh classification and the Mayo natural history model in the assessment of survival in patients with primary sclerosing cholangitis. Hepatology. 1999 Jun; 29 (6):1643-8
    View PubMed
  170. Brandhagen DJ, Gross JB Jr, Poterucha JJ, Charlton MR, Detmer J, Kolberg J, Gossard AA, Batts KP, Kim WR, Germer JJ, Wiesner RH, Persing DH. The clinical significance of simultaneous infection with hepatitis G virus in patients with chronic hepatitis C. Am J Gastroenterol. 1999 Apr; 94(4):1000-5.
    View PubMed
  171. Gross CR, Malinchoc M, Kim WR, Evans RW, Wiesner RH, Petz JL, Crippin JS, Klintmalm GB, Levy MF, Ricci P, Therneau TM, Dickson ER. Quality of life before and after liver transplantation for cholestatic liver disease. Hepatology. 1999 Feb; 29(2):356-64.
    View PubMed
  172. Kim WR, Wiesner RH, Therneau TM, Poterucha JJ, Porayko MK, Evans RW, Klintmalm GB, Crippin JS, Krom RA, Dickson ER. Optimal timing of liver transplantation for primary biliary cirrhosis. Hepatology. 1998 Jul; 28(1):33-8.
    View PubMed
  173. Kim WR, Dickson ER. Predictive models of natural history in primary biliary cirrhosis. Clin Liver Dis. 1998 May; 2 (2):313-31, ix
    View PubMed
  174. Kim WR, Poterucha JJ, Hermans JE, Therneau TM, Dickson ER, Evans RW, Gross JB Jr. Cost-effectiveness of 6 and 12 months of interferon-alpha therapy for chronic hepatitis C. Ann Intern Med. 1997 Nov 15; 127 (10):866-74
    View PubMed
  175. Kim WR, Poterucha JJ, Jorgensen RA, Batts KP, Homburger HA, Dickson ER, Krom RA, Wiesner RH, Lindor KD. Does antimitochondrial antibody status affect response to treatment in patients with primary biliary cirrhosis? Outcomes of ursodeoxycholic acid therapy and liver transplantation. Hepatology. 1997 Jul; 26 (1):22-6
    View PubMed
  176. Kim WR, Poterucha JJ, Porayko MK, Dickson ER, Steers JL, Wiesner RH. Recurrence of nonalcoholic steatohepatitis following liver transplantation. Transplantation. 1996 Dec 27; 62 (12):1802-5
    View PubMed
  177. Kim WR, Therneau TM, Dickson ER, Evans RW. Preoperative predictors of resource utilization in liver transplantation. Clin Transpl. 1995; 315-22.
    View PubMed
  178. Lee HS, Yoon JH, Kim WR, Kim CY. Relative etiologic role of hepatitis B virus and hepatitis C in HBsAg- negative patients with chronic liver disease in Korea. Korean J Intern Med. 1992; 42:8-15.
  179. Kim WR, Choi SW, Lee HS, Kim CY. The role of ascitic fluid protein concentration in the development of spontaneous bacterial peritonitis. Korean J Gastroenterol. 1990; 22:362-7.
  180. Kim WR, Chi JG. Embryogenesis of human liver. Chi. Korean Journal of Pathology. 1990; 18:222-225.
  181. Kwon HC, Kim WR, Chung HC, Lee HS, Kim CY. A case of primary biliary cirrhosis associated with Sjogren's syndrome. Korean J Gastroenterol. 1990; 22:453-9.
PST-20583112